Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis
TTAC-0001是一种全人源抗血管内皮生长因子受体2 (VEGFR-2/KDR)单克隆抗体,其抗癌活性与抑制肿瘤血管生成有关。
期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2015.1086854
Kim, Dong Geon; Jin, Younggeon; Jin, Juyoun; Yang, Heekyoung; Joo, Kyeung Min; Lee, Weon Sup; Shim, Sang Ryeol; Kim, Sung-Woo; Yoo, Jinsang; Lee, Sang Hoon; Yoo, Jin-San; Nam, Do-Hyun
单克隆抗体
KDR
肿瘤
肿瘤免疫
信号转导
EGF
心血管
EGFR
VEGF
血管生成